file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011 | |
Word(i) List (10782) Word count: 98586, All words count: 135005 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
201 | RECIPIENT | 197 | 875 | 2395 |
202 | GROWTH | 74 | 196 | 2380 |
203 | PREVENTION | 80 | 599 | 2373 |
204 | FACTOR | 104 | 194 | 2354 |
205 | GVHD | 97 | 342 | 2351 |
206 | HEPATIC | 41 | 164 | 2350 |
207 | CYTOTOXIC | 53 | 544 | 2345 |
208 | ORGAN | 137 | 687 | 2298 |
209 | HOST-DISEASE | 11 | 218 | 2297 |
210 | CYCLOSPORINE | 46 | 361 | 2286 |
211 | MANIFESTATIONS | 6 | 188 | 2285 |
212 | CHIMERA | 121 | 406 | 2272 |
213 | CHILDREN | 151 | 622 | 2269 |
214 | BLOCKADE | 90 | 940 | 2263 |
215 | FUSION | 56 | 128 | 2245 |
216 | HUMANIZED | 61 | 282 | 2226 |
217 | TUMOR | 81 | 120 | 2223 |
218 | ALPHA | 78 | 359 | 2221 |
219 | PURIFIED | 29 | 257 | 2217 |
220 | MUTATION | 26 | 96 | 2209 |
221 | COMPLETE | 94 | 571 | 2196 |
222 | DNA | 112 | 631 | 2179 |
223 | ANTIBODIES | 112 | 238 | 2161 |
224 | HL-A-MATCHED | 1 | 179 | 2146 |
225 | PORCINE | 59 | 361 | 2146 |
226 | B-CELL | 50 | 118 | 2145 |
227 | MALIGNANT | 24 | 580 | 2140 |
228 | ACTIVATION | 64 | 181 | 2130 |
229 | USE | 108 | 462 | 2126 |
230 | T-CELLS | 65 | 460 | 2125 |
# | Word | Recs | TLCS | TGCS |
231 | HLA-IDENTICAL | 51 | 391 | 2118 |
232 | FOREIGN | 5 | 442 | 2104 |
233 | TREATED | 72 | 433 | 2103 |
234 | RISK | 67 | 487 | 2085 |
235 | XENOGENEIC | 80 | 1139 | 2076 |
236 | SCID | 104 | 236 | 2065 |
237 | STABLE | 104 | 1103 | 2058 |
238 | CHARACTERIZATION | 79 | 516 | 2054 |
239 | GREEN | 20 | 133 | 2052 |
240 | ANTI-LEUKEMIC | 3 | 236 | 2018 |
241 | TOTAL | 81 | 807 | 2013 |
242 | BETA | 60 | 205 | 1999 |
243 | EMBRYOS | 62 | 194 | 1989 |
244 | RESPONSE | 99 | 426 | 1980 |
245 | QUAIL-CHICK | 19 | 124 | 1977 |
246 | CELLULAR | 84 | 290 | 1973 |
247 | ACTIVITY | 73 | 268 | 1966 |
248 | UMBILICAL | 80 | 295 | 1957 |
249 | NONMALIGNANT | 8 | 504 | 1948 |
250 | CADAVERIC | 19 | 289 | 1943 |
251 | POLYMERASE | 80 | 1051 | 1942 |
252 | KILLER | 52 | 252 | 1937 |
253 | THYMIC | 67 | 524 | 1908 |
254 | VIRUS | 76 | 128 | 1907 |
255 | CONVENTIONAL | 24 | 525 | 1899 |
256 | DIFFERENTIATE | 6 | 105 | 1889 |
257 | DELETION | 56 | 912 | 1887 |
258 | TECHNIQUE | 27 | 190 | 1879 |
259 | INFLUENCE | 58 | 411 | 1876 |
260 | PREPARATIVE | 35 | 883 | 1873 |
# | Word | Recs | TLCS | TGCS |
261 | MAJOR | 97 | 513 | 1871 |
262 | FATE | 41 | 159 | 1857 |
263 | STEM-CELLS | 37 | 628 | 1855 |
264 | CONTRIBUTION | 38 | 174 | 1844 |
265 | MYELOID-LEUKEMIA | 22 | 384 | 1837 |
266 | EXPERIMENTAL | 91 | 131 | 1832 |
267 | ISLET | 88 | 567 | 1827 |
268 | EPITHELIUM | 41 | 158 | 1816 |
269 | PRIMATES | 51 | 449 | 1816 |
270 | RADIATION | 114 | 510 | 1814 |
271 | RECOMBINANT | 54 | 259 | 1796 |
272 | RECURRENT | 19 | 329 | 1794 |
273 | HIGH | 81 | 504 | 1789 |
274 | TRANSGENIC | 55 | 74 | 1788 |
275 | IMMUNITY | 46 | 297 | 1787 |
276 | NOD | 82 | 357 | 1783 |
277 | OUTCOMES | 38 | 258 | 1763 |
278 | PROPHYLAXIS | 23 | 111 | 1759 |
279 | LETHAL | 28 | 544 | 1752 |
280 | DEVELOPMENTAL | 28 | 131 | 1745 |
281 | RESIDUAL | 109 | 719 | 1745 |
282 | BASILIXIMAB | 49 | 227 | 1735 |
283 | GRAFTED | 36 | 298 | 1726 |
284 | MYOGENIC | 5 | 81 | 1716 |
285 | CD8 | 92 | 440 | 1714 |
286 | OVAL | 2 | 76 | 1705 |
287 | COMPARED | 24 | 203 | 1697 |
288 | VITRO | 64 | 216 | 1697 |
289 | ADOPTIVE | 67 | 383 | 1696 |
290 | MYELOMA | 45 | 492 | 1692 |
# | Word | Recs | TLCS | TGCS |
291 | NON-HODGKIN | 26 | 114 | 1687 |
292 | HUMANS | 34 | 286 | 1686 |
293 | RAPID | 79 | 475 | 1671 |
294 | SYSTEMIC | 54 | 510 | 1666 |
295 | RECEPTORS | 49 | 164 | 1658 |
296 | INJURY | 60 | 98 | 1656 |
297 | LIGAND | 36 | 431 | 1654 |
298 | MULTI-LINEAGE | 5 | 124 | 1653 |
299 | MULTI-ORGAN | 2 | 109 | 1650 |
300 | MATERNAL | 63 | 359 | 1646 |
301 | LEADS | 32 | 612 | 1645 |
302 | MINIMAL | 111 | 650 | 1644 |
303 | NON-MYELOABLATIVE | 146 | 726 | 1642 |
304 | UTERO | 121 | 711 | 1641 |
305 | UBIQUITOUS | 3 | 111 | 1631 |
306 | CONTRIBUTE | 41 | 161 | 1628 |
307 | MECHANISMS | 71 | 517 | 1628 |
308 | CARCINOMA | 39 | 278 | 1624 |
309 | FULLY | 53 | 551 | 1624 |
310 | FORMATION | 48 | 62 | 1612 |
311 | REPORT | 65 | 383 | 1612 |
312 | GENETIC | 66 | 388 | 1603 |
313 | REFRACTORY | 62 | 400 | 1602 |
314 | MAN | 4 | 113 | 1595 |
315 | HAPLOIDENTICAL | 84 | 341 | 1577 |
316 | PRIMARY | 61 | 229 | 1575 |
317 | TRIAL | 33 | 139 | 1571 |
318 | PRIMERS | 7 | 185 | 1569 |
319 | PATIENT | 130 | 312 | 1568 |
320 | MIGRATION | 43 | 219 | 1567 |
# | Word | Recs | TLCS | TGCS |
321 | PHENOTYPE | 51 | 234 | 1563 |
322 | YEARS | 38 | 615 | 1552 |
323 | REGIMENS | 57 | 485 | 1545 |
324 | CLINICOPATHOLOGIC | 3 | 110 | 1538 |
325 | BLOCKING | 9 | 229 | 1534 |
326 | BONE-MARROW-DERIVED | 12 | 268 | 1533 |
327 | BODY | 57 | 771 | 1530 |
328 | CELL-MIGRATION | 6 | 915 | 1530 |
329 | TYPING | 21 | 132 | 1528 |
330 | INCLUDING | 16 | 79 | 1521 |
331 | EPITHELIAL | 41 | 165 | 1511 |
332 | HLA-DR | 7 | 84 | 1509 |
333 | PATHWAYS | 14 | 167 | 1503 |
334 | DONOR-RECIPIENT | 9 | 134 | 1501 |
335 | LOW-GRADE | 6 | 45 | 1495 |
336 | MATCHING | 16 | 114 | 1493 |
337 | TYPE | 88 | 154 | 1481 |
338 | IDENTIFICATION | 47 | 168 | 1474 |
339 | MOLECULAR | 103 | 239 | 1474 |
340 | CD40 | 25 | 253 | 1465 |
341 | REQUIRED | 48 | 361 | 1461 |
342 | MALE | 27 | 490 | 1456 |
343 | REDUCED | 134 | 286 | 1456 |
344 | INTRATHYMIC | 40 | 601 | 1453 |
345 | SEQUENCE-SPECIFIC | 6 | 100 | 1450 |
346 | INTESTINAL | 47 | 106 | 1449 |
347 | BRAIN | 40 | 90 | 1447 |
348 | SEATTLE | 1 | 108 | 1447 |
349 | LEUKOCYTES | 34 | 364 | 1446 |
350 | HIGH-DOSE | 23 | 410 | 1443 |
# | Word | Recs | TLCS | TGCS |
351 | STRAIN | 14 | 110 | 1436 |
352 | INCREASED | 40 | 283 | 1431 |
353 | NONHUMAN | 46 | 351 | 1427 |
354 | SEROLOGICAL | 5 | 68 | 1427 |
355 | CONSENSUS | 2 | 186 | 1425 |
356 | CONFERENCE | 3 | 185 | 1423 |
357 | GRADING | 1 | 185 | 1422 |
358 | PCR-SSP | 6 | 84 | 1422 |
359 | BOVINE | 12 | 206 | 1414 |
360 | CYTOREDUCTION | 4 | 427 | 1403 |
361 | HOURS | 2 | 66 | 1398 |
362 | CYTOGENETIC | 30 | 218 | 1397 |
363 | CLINICAL-PRACTICE | 1 | 66 | 1392 |
364 | CD28 | 13 | 206 | 1382 |
365 | METHOTREXATE | 12 | 86 | 1377 |
366 | TOXICITY | 40 | 218 | 1376 |
367 | MARKER | 36 | 84 | 1374 |
368 | MORTALITY | 23 | 168 | 1369 |
369 | BARRIERS | 44 | 552 | 1367 |
370 | IDEC-C2B8 | 4 | 43 | 1367 |
371 | EXPERIENCE | 72 | 315 | 1358 |
372 | GENES | 31 | 39 | 1358 |
373 | IMMUNOLOGICAL | 58 | 225 | 1358 |
374 | CREST | 27 | 63 | 1354 |
375 | EVALUATION | 96 | 664 | 1347 |
376 | REACTIVITY | 33 | 413 | 1334 |
377 | METASTATIC | 30 | 295 | 1333 |
378 | CHAIN | 61 | 357 | 1330 |
379 | SYNGENEIC | 41 | 616 | 1328 |
380 | GENERATION | 50 | 107 | 1326 |
# | Word | Recs | TLCS | TGCS |
381 | GRAFT-VERSUS-TUMOR | 19 | 371 | 1325 |
382 | ALLOREACTIVITY | 20 | 160 | 1324 |
383 | STROMAL | 40 | 177 | 1322 |
384 | AUTOLOGOUS | 86 | 203 | 1315 |
385 | DIABETIC | 42 | 198 | 1315 |
386 | LOW | 77 | 222 | 1303 |
387 | SCID-HU | 10 | 123 | 1303 |
388 | ANEMIA | 81 | 320 | 1301 |
389 | FOLLOWED | 60 | 450 | 1300 |
390 | LUNG | 94 | 291 | 1294 |
391 | PIG | 37 | 235 | 1286 |
392 | CHAIN-REACTION | 34 | 746 | 1275 |
393 | SICKLE | 58 | 372 | 1274 |
394 | HIGH-RISK | 32 | 204 | 1270 |
395 | CAPACITY | 24 | 71 | 1260 |
396 | COMBINATION | 42 | 197 | 1260 |
397 | INFECTION | 57 | 98 | 1257 |
398 | MACROPHAGE | 26 | 120 | 1256 |
399 | IMMUNOSUPPRESSIVE | 48 | 446 | 1253 |
400 | NUCLEAR | 24 | 24 | 1243 |